276 related articles for article (PubMed ID: 24722055)
1. Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
Gąssowska M; Czapski GA; Pająk B; Cieślik M; Lenkiewicz AM; Adamczyk A
PLoS One; 2014; 9(4):e94259. PubMed ID: 24722055
[TBL] [Abstract][Full Text] [Related]
2. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization.
Hongo H; Kihara T; Kume T; Izumi Y; Niidome T; Sugimoto H; Akaike A
Biochem Biophys Res Commun; 2012 Sep; 426(1):94-9. PubMed ID: 22922102
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.
Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T
FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T; Duka V; Joyce JN; Sidhu A
FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
[TBL] [Abstract][Full Text] [Related]
7. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
8. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
9. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H₂O₂.
Feng Y; Xia Y; Yu G; Shu X; Ge H; Zeng K; Wang J; Wang X
J Neurochem; 2013 Jul; 126(2):234-42. PubMed ID: 23646926
[TBL] [Abstract][Full Text] [Related]
11. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
[TBL] [Abstract][Full Text] [Related]
12. [Study of the protection and mechanism of IGF-1 on tau protein hyperphosphorylation in PC12 cells induced by Abeta(1-40)].
Wang PJ; Zhang Y; Song RR; Shen DF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):960-4. PubMed ID: 21265094
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.
Wang Y; Liu W; He X; Zhou F
J Mol Neurosci; 2013 Nov; 51(3):911-8. PubMed ID: 23979838
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
[TBL] [Abstract][Full Text] [Related]
15. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
Hu M; Waring JF; Gopalakrishnan M; Li J
J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
[TBL] [Abstract][Full Text] [Related]
16. Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.
Kozikowski AP; Gaisina IN; Petukhov PA; Sridhar J; King LT; Blond SY; Duka T; Rusnak M; Sidhu A
ChemMedChem; 2006 Feb; 1(2):256-66. PubMed ID: 16892358
[TBL] [Abstract][Full Text] [Related]
17. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
Chatterjee S; Sang TK; Lawless GM; Jackson GR
Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
[TBL] [Abstract][Full Text] [Related]
20. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
